Amarin Wins FDA Panel Nod to Expand Heart Drug Vascepa’s Label

(Bloomberg) -- Amarin Corp. shares may extend their recent gains after an advisory panel to the U.S. Food and Drug Administration voted unanimously in favor of expanding the label for its heart dru...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.